The Gynecological Cancer Clinical Program provides compassionate, multidisciplinary care that is informed by research to develop the most effective therapies for patients with ovarian cancer, endometrial cancer and cervical cancer. Our nationally recognized specialty physicians provide education, care and support needed to help patients navigate diagnosis and treatment plan.
Hematology/Oncology Gynecological Cancer Program in partnership Division of Gynecological Oncology and the Jordan Center for Gynecologic Cancers has a comprehensive team of sub-specialist medical oncologists, gyne onc surgeons, radiation oncologist, pathologists, radiologists, nurse practitioners, and oncology nurse navigators. This group meets weekly to discuss treatment plans for patients, resulting in advanced and personalized treatment plans for each patient.
Penn oncologists are national and international leaders in developing and testing new therapies for cancer treatment and they are engaged in a broad range of basic and clinical research, clinical care and teaching related to the diagnosis and treatment of ovarian cancer, uterine cancer and cervical cancer. Dedicated teams for patents with gynecological malignancies are also available at Penn Medicine Valley Forge, Penn Medicine Radnor, Chester County Hospital Pennsylvania Hospital and at Cherry Hill.
A dedicated clinical trials staff offers multiple clinical trials including studies of:
- Targeted molecular therapy
- Clinical trials
Individualized treatment approaches that include the pathological analysis of tumor material in order to personalize medical treatments are also being investigated.
The Basser Center for BRCA is the first comprehensive center for research, treatment and prevention of BRCA related cancers including ovarian cancer.
Medical oncologists involved in the management of gynecological malignancies include: